Various gene silencing technologies like siRNA, miRNA, ribozymes, DNAzymes have shown promise as therapeutics agents against viral diseases. RNAi-based drugs against viruses such as ebola virus ...

Various gene silencing technologies like siRNA, miRNA, ribozymes, DNAzymes have shown promise as therapeutics agents against viral diseases. RNAi-based drugs against viruses such as ebola virus ...

Herpes simplex virus type I (HSV-1) is a member of the α-herpesvirus subfamily and is capable of causing herpes simplex keratitis, herpes labialis, and herpes simplex encephalitis. HSV-1 is well known ...

Once the domain of immunologists, flow cytometry applications are making their way into mainstream cell and molecular biology—from analyzing gene knockdowns with siRNA, to elucidating entire ...

PORTLAND, IN, UNITED STATES, January 28, 2025 /EINPresswire / -- The RNA based therapeutics has been explored as a promising treatment option for the diseases which are difficult to treat. Development ...

siRNA was introduced into the cells at a final concentration of 5 nM, and the total RNA was extracted with ISOGEN after 48 h. Similarly, 20 nM miR-3145-3p inhibitor (miRCURY miRNA inhibitor Y104 ...

Finally are "genetic medicines", including gene therapy, gene editing, siRNA, mRNA and microRNA. The growth in US healthcare expenditures will be driven by age demographics and the prevalence of ...

Abstract: In recent years, microRNA (miRNA) has been recognized as crucial in the progression of human diseases. However, existing computational methods for identifying miRNAdisease associations often ...

Benitec has a market cap of $250mn, $67.8mn in cash, and a cash runway of over 10 quarters, but faces risks due to its small ...

January 14, 2025 • Syria's new rulers faces one of their first serious challenges: bread lines. For Syrians, the long wait is a struggle — but for some, bread is a business opportunity.